Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma
April 1999
The FDA just approved Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma.
Alitretinoin is a form of retinoic acid.
It's applied to skin lesions to inhibit cell growth...it doesn't prevent new lesions or treat systemic disease.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote